Latest Methylphenidate Stories

Evidence that brain's reward/motivation circuits are linked to compulsive overeatingA brain imaging study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory reveals a subtle difference between ordinary obese subjects and those who compulsively overeat, or binge: In binge eaters but not ordinary obese subjects, the mere sight or smell of favorite foods triggers a spike in dopamine "” a brain chemical linked to reward and motivation. The findings "” published online on...

Among the many differences between girls and boys, add the effects from caffeine -- physiological, behavioral and subjective -- to the list.Results of a double-blind, placebo-controlled, dose-response study of the response of youth to caffeine found that, in general, boys get a greater rush and more energy from caffeine than girls.Boys also reported they felt that caffeine had a positive effect on their athletic performance. Girls didn't report on this issue.The study, conducted by Jennifer...

EL CAJON, Calif., Feb. 9, 2011 /PRNewswire/ -- On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis--muscle breakdown--are so rare that it suggests an additional causal factor, such as a drug. Drugs known as 'statins,' widely used to lower cholesterol, are known in rare cases to cause rhabdomyolysis. It seems more likely, however, that amphetamines, prescribed...

Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a team of Penn State neuroscientists. This may have implications for iron-deficient human infants as well.The researchers found that low doses of Ritalin can help improve the focus of iron-deficient rats. Higher doses proved to hurt rather than help the control animals' focus, making them hyperactive. The control rats that were not iron deficient but received low doses of Ritalin...

Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have difficulty in concentrating. The study, by experts at The University of Nottingham, may explain why parents often say that their child can maintain concentration when they are doing something that interests them, but struggles with boring tasks.Using a 'Whac-a-Mole' style game, researchers from the Motivation, Inhibition and Development...

Brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have shown for the first time why people affected by the condition sometimes have such difficulty in concentrating. The study, funded by the Wellcome Trust, may explain why parents often say that their child can maintain concentration when they are doing something that interests them, but struggles with boring tasks.Using a 'Whac-a-Mole' style game, researchers from the Motivation, Inhibition and Development in ADHD...

BURLINGTON, Mass., Dec. 6, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019. An expanding drug-treated...

Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every...

PISGAH FOREST, N.C., Nov. 4, 2010 /PRNewswire/ -- Pisgah Labs, Inc. (http://www.pisgahlabs.com), an innovative drug development and active ingredient manufacturer located in Western North Carolina, has received a substantial federal grant. The Qualifying Therapeutic Discovery Project Program (http://www.grants.nih.gov/grants/funding/QTDP_PIM/index.htm) made funding available to promising new technologies ready for pre-clinical or clinical trials, and to support filing of a New Drug...

TITUSVILLE, N.J., Nov. 2, 2010 /PRNewswire/ -- Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) today announced it has entered into a supply and distribution agreement with Watson Laboratories, Inc. to distribute an authorized generic version of CONCERTA® (methylphenidate HCl extended-release tablets). Watson will launch the authorized generic beginning May 1, 2011. "The availability of an authorized generic version of CONCERTA that is both bioequivalent and clinically equivalent to...